Primary human macrophages serve as vehicles for vaccinia virus replication and dissemination

Journal of Virology

Volumn 88, Issue 12, 2014, Pages 6819-6831

  Byrd, Daniel ^a   Shepherd, Nicole ^a   Lan, Jie ^a   Hu, Ningjie ^b   Amet, Tohti ^a   Yang, Kai ^a,b   Desai, Mona ^a   Yu, Qigui ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; STAT3 PROTEIN; VIRUS DNA;

ARTICLE; CELL LYSATE; CELL SPREADING; CONTROLLED STUDY; DESMOSOME; ENZYME INHIBITION; HUMAN; HUMAN CELL; MACROPHAGE; MACROPHAGE ACTIVATION; NONHUMAN; PRIMARY CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VACCINIA VIRUS; VIRION; VIRUS CARRIER; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS LOAD; VIRUS RELEASE; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANIMALS; CELLS, CULTURED; HUMANS; INTERLEUKIN-1; INTERLEUKIN-10; MACROPHAGES; MICE; MONOCYTES; VACCINIA; VACCINIA VIRUS; VIRUS REPLICATION;

EID: 84901308508     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03726-13     Document Type: Article

References (87)

1. Jahrling PB, Hensley LE, Martinez MJ, Leduc JW, Rubins KH, Relman DA, Huggins JW. 2004. Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox. Proc. Natl. Acad. Sci. U. S. A. 101:15196-15200. http://dx.doi.org/10.1073/pnas.0405954101.
2. Wahl-Jensen V, Cann JA, Rubins KH, Huggins JW, Fisher RW, Johnson AJ, de Kok-Mercado F, Larsen T, Raymond JL, Hensley LE, Jahrling PB. 2011. Progression of pathogenic events in cynomolgus macaques infected with variola virus. PLoS One 6:e24832. http://dx.doi.org/10.1371/journal.pone.0024832.
3. Tsuru S, Kitani H, Seno M, Abe M, Zinnaka Y, Nomoto K. 1983. Mechanism of protection during the early phase of a generalized viral infection. I. Contribution of phagocytes to protection against ectromelia virus. J. Gen. Virol. 64(Part 9):2021-2026.
4. Karupiah G, Buller RM, Van Rooijen N, Duarte CJ, Chen J. 1996. Different roles for CD4 and CD8 T lymphocytes and macrophage subsets in the control of a generalized virus infection. J. Virol. 70:8301-8309.
5. Roberts JA. 1964. Growth of virulent and attenuated ectromelia virus in cultured macrophages from normal and ectromeliaimmune mice. J. Immunol. 92:837-842.
6. Kochneva GV, Urmanov IH, Ryabchikova EI, Streltsov VV, Serpinsky OI. 1994. Fine mechanisms of ectromelia virus thymidine kinase-negative mutants avirulence. Virus Res. 34:49-61. http://dx.doi.org/10.1016/0168-1702(94)90118-X.
7. Damon IK. 2007. Poxviruses, p 2947-2976. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
8. Smith GL, Vanderplasschen A, Law M. 2002. The formation and function of extracellular enveloped vaccinia virus. J. Gen. Virol. 83:2915-2931. http://vir.sgmjournals.org/content/83/12/2915.
9. Doceul V, Hollinshead M, van der Linden L, Smith GL. 2010. Repulsion of superinfecting virions: a mechanism for rapid virus spread. Science 327:873-876. http://dx.doi.org/10.1126/science.1183173.
10. Hickman HD, Reynoso GV, Ngudiankama BF, Rubin EJ, Magadan JG, Cush SS, Gibbs J, Molon B, Bronte V, Bennink JR, Yewdell JW. 2013. Anatomically restricted synergistic antiviral activities of innate and adaptive immune cells in the skin. Cell Host Microbe 13:155-168. http://dx.doi.org/10.1016/j.chom.2013.01.004.
11. Broder CC, Kennedy PE, Michaels F, Berger EA. 1994. Expression of foreign genes in cultured human primary macrophages using recombinant vaccinia virus vectors. Gene 142:167-174. http://dx.doi.org/10.1016/0378-1119(94)90257-7.
12. Drillien R, Spehner D, Bohbot A, Hanau D. 2000. Vaccinia virus-related events and phenotypic changes after infection of dendritic cells derived from human monocytes. Virology 268:471-481. http://dx.doi.org/10.1006/viro.2000.0203.
13. Engelmayer J, Larsson M, Subklewe M, Chahroudi A, Cox WI, Steinman RM, Bhardwaj N. 1999. Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J. Immunol. 163:6762-6768.
14. Jenne L, Hauser C, Arrighi JF, Saurat JH, Hugin AW. 2000. Poxvirus as a vector to transduce human dendritic cells for immunotherapy: abortive infection but reduced APC function. Gene Ther. 7:1575-1583. http://dx.doi.org/10.1038/sj.gt.3301287.
15. Subklewe M, Chahroudi A, Schmaljohn A, Kurilla MG, Bhardwaj N, Steinman RM. 1999. Induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses using dendritic cells pulsed with EBNA-3A peptides or UV-inactivated, recombinant EBNA-3A vaccinia virus. Blood 94: 1372-1381.
16. Bronte V, Carroll MW, Goletz TJ, Wang M, Overwijk WW, Marincola F, Rosenberg SA, Moss B, Restifo NP. 1997. Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine. Proc. Natl. Acad. Sci. U. S. A. 94: 3183-3188. http://dx.doi.org/10.1073/pnas.94.7.3183.
17. Chahroudi A, Garber DA, Reeves P, Liu L, Kalman D, Feinberg MB. 2006. Differences and similarities in viral life cycle progression and host cell physiology after infection of human dendritic cells with modified vaccinia virus Ankara and vaccinia virus. J. Virol. 80:8469-8481. http://dx.doi.org/10.1128/JVI.02749-05.
18. Liu L, Xu Z, Fuhlbrigge RC, Pena-Cruz V, Lieberman J, Kupper TS. 2005. Vaccinia virus induces strong immunoregulatory cytokine production in healthy human epidermal keratinocytes: a novel strategy for immune evasion. J. Virol. 79:7363-7370. http://dx.doi.org/10.1128/JVI.79.12.7363-7370.2005.
19. Musson RA. 1983. Human serum induces maturation of human monocytes in vitro. Changes in cytolytic activity, intracellular lysosomal enzymes, and nonspecific esterase activity. Am. J. Pathol. 111:331-340.
20. Eischen A, Vincent F, Bergerat JP, Louis B, Faradji A, Bohbot A, Oberling F. 1991. Long term cultures of human monocytes in vitro. Impact of GM-CSF on survival and differentiation. J. Immunol. Methods 143:209-221.
21. Suzu S, Yokota H, Yamada M, Yanai N, Saito M, Kawashima T, Saito M, Takaku F, Motoyoshi K. 1989. Enhancing effect of human monocytic colony-stimulating factor on monocyte tumoricidal activity. Cancer Res. 49:5913-5917.
22. Helinski EH, Bielat KL, Ovak GM, Pauly JL. 1988. Long-term cultivation of functional human macrophages in Teflon dishes with serum-free media. J. Leukoc. Biol. 44:111-121.
23. Vogel SN, Perera PY, Hogan MM, Majde JA. 1988. Use of serum-free, compositionally defined medium for analysis of macrophage differentiation in vitro. J. Leukoc. Biol. 44:136-142.
24. Jaguin M, Houlbert N, Fardel O, Lecureur V. 2013. Polarization profiles of human M-CSF-generated macrophages and comparison of M1-markers in classically activated macrophages from GM-CSF and M-CSF origin. Cell. Immunol. 281:51-61. http://dx.doi.org/10.1016/j.cellimm.2013.01.010.
25. Loke P, Nair MG, Parkinson J, Guiliano D, Blaxter M, Allen JE. 2002. IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype. BMCImmunol. 3:7. http://dx.doi.org/10.1186/1471-2172-3-7.
26. Ghassabeh GH, De Baetselier P, Brys L, Noel W, Van Ginderachter JA, Meerschaut S, Beschin A, Brombacher F, Raes G. 2006. Identification of a common gene signature for type II cytokine-associated myeloid cells elicited in vivo in different pathologic conditions. Blood 108:575-583. http://dx.doi.org/10.1182/blood-2005-04-1485.
27. Sica A, Mantovani A. 2012. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Investig. 122:787-795. http://dx.doi.org/10.1172/JCI59643.
28. Norbury CC, Malide D, Gibbs JS, Bennink JR, Yewdell JW. 2002. Visualizing priming of virus-specific CD8 T cells by infected dendritic cells in vivo. Nat. Immunol. 3:265-271. http://dx.doi.org/10.1038/ni762.
29. Katsafanas GC, Moss B. 2007. Colocalization of transcription and translation within cytoplasmic poxvirus factories coordinates viral expression and subjugates host functions. Cell Host Microbe 2:221-228. http://dx.doi.org/10.1016/j.chom.2007.08.005.
30. Law M, Smith GL. 2004. Studying the binding and entry of the intracellular and extracellular enveloped forms of vaccinia virus. Methods Mol. Biol. 269:187-204. http://dx.doi.org/10.1385/1-59259-789-0:187.
31. T) method. Methods 25:402-408. http://dx.doi.org/10.1006/meth.2001.1262.
32. Herrera E, Lorenzo MM, Blasco R, Isaacs SN. 1998. Functional analysis of vaccinia virus B5R protein: essential role in virus envelopment is independent of a large portion of the extracellular domain. J. Virol. 72:294-302.
33. Payne LG, Norrby E. 1976. Presence of haemagglutinin in the envelope of extracellular vaccinia virus particles. J. Gen. Virol. 32:63-72. http://dx.doi.org/10.1099/0022-1317-32-1-63.
34. Young DA, Lowe LD, Clark SC. 1990. Comparison of the effects of IL-3, granulocyte-macrophage colony-stimulating factor, and macrophage colonystimulating factor in supporting monocyte differentiation in culture. Analysis of macrophage antibody-dependent cellular cytotoxicity. J. Immunol. 145:607-615.
35. Chahroudi A, Chavan R, Kozyr N, Waller EK, Silvestri G, Feinberg MB. 2005. Vaccinia virus tropism for primary hematolymphoid cells is determined by restricted expression of a unique virus receptor. J. Virol. 79: 10397-10407. http://dx.doi.org/10.1128/JVI.79.16.10397-10407.2005.
36. Humlova Z, Vokurka M, Esteban M, Melkova Z. 2002. Vaccinia virus induces apoptosis of infected macrophages. J. Gen. Virol. 83:2821-2832. http://vir.sgmjournals.org/content/83/11/2821.
37. Fahy RJ, DoseffAI, Wewers MD. 1999. Spontaneous human monocyte apoptosis utilizes a caspase-3-dependent pathway that is blocked by endotoxin and is independent of caspase-1. J. Immunol. 163:1755-1762.
38. Mercer J, Helenius A. 2008. Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 320:531-535. http://dx.doi.org/10.1126/science.1155164.
39. Jemielity S, Wang JJ, Chan YK, Ahmed AA, Li W, Monahan S, Bu X, Farzan M, Freeman GJ, Umetsu DT, DekruyffRH, Choe H. 2013. TIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserine. PLoS Pathog. 9:e1003232. http://dx.doi.org/10.1371/journal.ppat.1003232.
40. Tolonen N, Doglio L, Schleich S, Krijnse Locker J. 2001. Vaccinia virus DNA replication occurs in endoplasmic reticulum-enclosed cytoplasmic mini-nuclei. Mol. Biol. Cell 12:2031-2046. http://dx.doi.org/10.1091/mbc.12.7.2031.
41. Frischknecht F, Moreau V, Rottger S, Gonfloni S, Reckmann I, Superti-Furga G, Way M. 1999. Actin-based motility of vaccinia virus mimics receptor tyrosine kinase signalling. Nature 401:926-929. http://dx.doi.org/10.1038/44860.
42. Reeves PM, Bommarius B, Lebeis S, McNulty S, Christensen J, Swimm A, Chahroudi A, Chavan R, Feinberg MB, Veach D, Bornmann W, Sherman M, Kalman D. 2005. Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases. Nat. Med. 11:731-739. http://dx.doi.org/10.1038/nm1265.
43. Sanderson CM, Way M, Smith GL. 1998. Virus-induced cell motility. J. Virol. 72:1235-1243.
44. Boulter EA, Appleyard G. 1973. Differences between extracellular and intracellular forms of poxvirus and their implications. Prog. Med. Virol. 16:86-108.
45. de Magalhaes JC, Andrade AA, Silva PN, Sousa LP, Ropert C, Ferreira PC, Kroon EG, Gazzinelli RT, Bonjardim CA. 2001. A mitogenic signal triggered at an early stage of vaccinia virus infection: implication of MEK/ERK and protein kinase A in virus multiplication. J. Biol. Chem. 276: 38353-38360. http://dx.doi.org/10.1074/jbc. M100183200.
46. Andrade AA, Silva PN, Pereira AC, De Sousa LP, Ferreira PC, Gazzinelli RT, Kroon EG, Ropert C, Bonjardim CA. 2004. The vaccinia virus-stimulated mitogen-activated protein kinase (MAPK) pathway is required for virus multiplication. Biochem. J. 381:437-446. http://dx.doi.org/10.1042/BJ20031375.
47. Soares JA, Leite FG, Andrade LG, Torres AA, De Sousa LP, Barcelos LS, Teixeira MM, Ferreira PC, Kroon EG, Souto-Padron T, Bonjardim CA. 2009. Activation of the PI3K/Akt pathway early during vaccinia and cowpox virus infections is required for both host survival and viral replication. J. Virol. 83:6883-6899. http://dx.doi.org/10.1128/JVI.00245-09.
48. Izmailyan R, Hsao JC, Chung CS, Chen CH, Hsu PW, Liao CL, Chang W. 2012. Integrin beta1 mediates vaccinia virus entry through activation of PI3K/Akt signaling. J. Virol. 86:6677-6687. http://dx.doi.org/10.1128/JVI.06860-11.
49. Byrd D, Amet T, Hu N, Lan J, Hu S, Yu Q. 2013. Primary human leukocyte subsets differentially express vaccinia virus receptors enriched in lipid rafts. J. Virol. 87:9301-9312. http://dx.doi.org/10.1128/JVI.01545-13.
50. Chan WM, Bartee EC, Moreb JS, Dower K, Connor JH, McFadden G. 2013. Myxoma and vaccinia viruses bind differentially to human leukocytes. J. Virol. 87:4445-4460. http://dx.doi.org/10.1128/JVI.03488-12.
51. Yu Q, Hu N, Ostrowski M. 2009. Poxvirus tropism for primary human leukocytes and hematopoietic cells. Methods Mol. Biol. 515:309-328. http://dx.doi.org/10.1007/978-1-59745-559-6_22.
52. Sanchez-Puig JM, Sanchez L, Roy G, Blasco R. 2004. Susceptibility of different leukocyte cell types to vaccinia virus infection. Virol. J. 1:10. http://dx.doi.org/10.1186/1743-422X-1-10.
53. Finnin M, Hamilton JA, Moss ST. 1999. Characterization of a CSFinduced proliferating subpopulation of human peripheral blood monocytes by surface marker expression and cytokine production. J. Leukoc. Biol. 66:953-960.
54. Fleetwood AJ, Lawrence T, Hamilton JA, Cook AD. 2007. Granulocytemacrophage colony-stimulating factor (CSF) and macrophage CSFdependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J. Immunol. 178:5245-5252. http://www.jimmunol.org/content/178/8/5245.
55. Fleetwood AJ, Dinh H, Cook AD, Hertzog PJ, Hamilton JA. 2009. GM-CSF-and M-CSF-dependent macrophage phenotypes display differential dependence on type I interferon signaling. J. Leukoc. Biol. 86:411-421. http://dx.doi.org/10.1189/jlb.1108702.
56. Lacey DC, Achuthan A, Fleetwood AJ, Dinh H, Roiniotis J, Scholz GM, Chang MW, Beckman SK, Cook AD, Hamilton JA. 2012. Defining GM-CSF-and macrophage-CSF-dependent macrophage responses by in vitro models. J. Immunol. 188:5752-5765. http://dx.doi.org/10.4049/jimmunol.1103426.
57. Liu G, Zhai Q, Schaffner DJ, Wu A, Yohannes A, Robinson TM, Maland M, Wells J, Voss TG, Bailey C, Alibek K. 2004. Prevention of lethal respiratory vaccinia infections in mice with interferon-alpha and interferon-gamma. FEMS Immunol. Med. Microbiol. 40:201-206. http://dx.doi.org/10.1016/S0928-8244(03)00358-4.
58. Smith GL, Benfield CT, Maluquer de Motes C, Mazzon M, Ember SW, Ferguson BJ, Sumner RP. 2013. Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity. J. Gen. Virol. 94:2367-2392. http://dx.doi.org/10.1099/vir.0.055921-0.
59. Downing JR, Rettenmier CW, Sherr CJ. 1988. Ligand-induced tyrosine kinase activity of the colony-stimulating factor 1 receptor in a murine macrophage cell line. Mol. Cell. Biol. 8:1795-1799.
60. Hamilton JA. 1997. CSF-1 signal transduction. J. Leukoc. Biol. 62:145-155.
61. Wang Y, Zeigler MM, Lam GK, Hunter MG, Eubank TD, Khramtsov VV, Tridandapani S, Sen CK, Marsh CB. 2007. The role of the NADPH oxidase complex, p38 MAPK, and Akt in regulating human monocyte/macrophage survival. Am. J. Respir. Cell Mol. Biol. 36:68-77. http://dx.doi.org/10.1165/rcmb.2006-0165OC.
62. Bhatt NY, Kelley TW, Khramtsov VV, Wang Y, Lam GK, Clanton TL, Marsh CB. 2002. Macrophage-colony-stimulating factor-induced activation of extracellular-regulated kinase involves phosphatidylinositol 3-kinase and reactive oxygen species in human monocytes. J. Immunol. 169: 6427-6434. http://www.jimmunol.org/content/169/11/6427.
63. Sengupta A, Liu WK, Yeung YG, Yeung DC, Frackelton AR, Jr, Stanley ER. 1988. Identification and subcellular localization of proteins that are rapidly phosphorylated in tyrosine in response to colony-stimulating factor 1. Proc. Natl. Acad. Sci. U. S. A. 85:8062-8066. http://dx.doi.org/10.1073/pnas.85.21.8062.
64. Platanias LC. 2003. Map kinase signaling pathways and hematologic malignancies. Blood 101:4667-4679. http://dx.doi.org/10.1182/blood-2002-12-3647.
65. Cross M, Nguyen T, Bogdanoska V, Reynolds E, Hamilton JA. 2005. A proteomics strategy for the enrichment of receptor-associated complexes. Proteomics 5:4754-4763. http://dx.doi.org/10.1002/pmic.200500058.
66. Guthridge MA, Stomski FC, Thomas D, Woodcock JM, Bagley CJ, Berndt MC, Lopez AF. 1998. Mechanism of activation of the GM-CSF, IL-3, and IL-5 family of receptors. Stem Cells 16:301-313. http://dx.doi.org/10.1002/stem.160301.
67. Hu N, Yu R, Shikuma C, Shiramizu B, Ostrwoski MA, Yu Q. 2009. Role of cell signaling in poxvirus-mediated foreign gene expression in mammalian cells. Vaccine 27:2994-3006. http://dx.doi.org/10.1016/j.vaccine.2009.02.103.
68. Rahbar R, Murooka TT, Fish EN. 2009. Role for CCR5 in dissemination of vaccinia virus in vivo. J. Virol. 83:2226-2236. http://dx.doi.org/10.1128/JVI.01655-08.
69. Rahbar R, Murooka TT, Hinek AA, Galligan CL, Sassano A, Yu C, Srivastava K, Platanias LC, Fish EN. 2006. Vaccinia virus activation of CCR5 invokes tyrosine phosphorylation signaling events that support virus replication. J. Virol. 80:7245-7259. http://dx.doi.org/10.1128/JVI.00463-06.
70. Cassol E, Cassetta L, Rizzi C, Alfano M, Poli G. 2009. M1 and M2a polarization of human monocyte-derived macrophages inhibits HIV-1 replication by distinct mechanisms. J. Immunol. 182:6237-6246. http://dx.doi.org/10.4049/jimmunol.0803447.
71. Yanguez E, Garcia-Culebras A, Frau A, Llompart C, Knobeloch KP, Gutierrez-Erlandsson S, Garcia-Sastre A, Esteban M, Nieto A, Guerra S. 2013. ISG15 regulates peritoneal macrophages functionality against viral infection. PLoS Pathog. 9:e1003632. http://dx.doi.org/10.1371/journal.ppat.1003632.
72. Perdiguero B, Esteban M. 2009. The interferon system and vaccinia virus evasion mechanisms. J. Interferon Cytokine Res. 29:581-598. http://dx.doi.org/10.1089/jir.2009.0073.
73. Martinez FO, Gordon S, Locati M, Mantovani A. 2006. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177:7303-7311. http://www.jimmunol.org/content/177/10/7303.
74. Way KJ, Dinh H, Keene MR, White KE, Clanchy FI, Lusby P, Roiniotis J, Cook AD, Cassady AI, Curtis DJ, Hamilton JA. 2009. The generation and properties of human macrophage populations from hemopoietic stem cells. J. Leukoc. Biol. 85:766-778. http://dx.doi.org/10.1189/jlb.1108689.
75. Stanley ER, Berg KL, Einstein DB, Lee PS, Pixley FJ, Wang Y, Yeung YG. 1997. Biology and action of colony-stimulating factor-1. Mol. Reprod. Dev. 46:4-10. http://dx.doi.org/10.1002/(SICI)1098-2795 (199701)46:14::AID-MRD23.0.CO;2-V.
76. Wiktor-Jedrzejczak W, Bartocci A, Ferrante AW, Jr, Ahmed-Ansari A, Sell KW, Pollard JW, Stanley ER. 1990. Total absence of colonystimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc. Natl. Acad. Sci. U. S. A. 87:4828-4832. http://dx.doi.org/10.1073/pnas.87.12.4828.
77. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25:677-686. http://dx.doi.org/10.1016/j.it.2004.09.015.
78. Mann BA, Huang JH, Li P, Chang HC, Slee RB, O'Sullivan A, Anita M, Yeh N, Klemsz MJ, Brutkiewicz RR, Blum JS, Kaplan MH. 2008. Vaccinia virus blocks Stat1-dependent and Stat1-independent gene expression induced by type I and type II interferons. J. Interferon Cytokine Res. 28:367-380. http://dx.doi.org/10.1089/jir.2007.0113.
79. Mantovani A, Locati M. 2013. Tumor-associated macrophages as a paradigm of macrophage plasticity, diversity, and polarization: lessons and open questions. Arterioscler. Thromb. Vasc. Biol. 33:1478-1483. http://dx.doi.org/10.1161/ATVBAHA.113.300168.
80. Klages K, Mayer CT, Lahl K, Loddenkemper C, Teng MW, Ngiow SF, Smyth MJ, Hamann A, Huehn J, Sparwasser T. 2010. Selective depletion of Foxp3 regulatory T cells improves effective therapeutic vaccination against established melanoma. Cancer Res. 70:7788-7799. http://dx.doi.org/10.1158/0008-5472.CAN-10-1736.
81. Teng MW, Ngiow SF, von Scheidt B, McLaughlin N, Sparwasser T, Smyth MJ. 2010. Conditional regulatory T-cell depletion releases adaptive immunity preventing carcinogenesis and suppressing established tumor growth. Cancer Res. 70:7800-7809. http://dx.doi.org/10.1158/0008-5472.CAN-10-1681.
82. Teng MW, Swann JB, von Scheidt B, Sharkey J, Zerafa N, McLaughlin N, Yamaguchi T, Sakaguchi S, Darcy PK, Smyth MJ. 2010. Multiple antitumor mechanisms downstream of prophylactic regulatory T-cell depletion. Cancer Res. 70:2665-2674. http://dx.doi.org/10.1158/0008-5472.CAN-09-1574.
83. Kirn DH, Wang Y, Liang W, Contag CH, Thorne SH. 2008. Enhancing poxvirus oncolytic effects through increased spread and immune evasion. Cancer Res. 68:2071-2075. http://dx.doi.org/10.1158/0008-5472.CAN-07-6515.
84. Blasco R, Moss B. 1992. Role of cell-associated enveloped vaccinia virus in cell-to-cell spread. J. Virol. 66:4170-4179.
85. Payne LG. 1979. Identification of the vaccinia hemagglutinin polypeptide from a cell system yielding large amounts of extracellular enveloped virus. J. Virol. 31:147-155.
86. Reeves PM, Smith SK, Olson VA, Thorne SH, Bornmann W, Damon IK, Kalman D. 2011. Variola and monkeypox viruses utilize conserved mechanisms of virion motility and release that depend on abl and SRC family tyrosine kinases. J. Virol. 85:21-31. http://dx.doi.org/10.1128/JVI.01814-10.
87. McNulty S, Powell K, Erneux C, Kalman D. 2011. The host phosphoinositide 5-phosphatase SHIP2 regulates dissemination of vaccinia virus. J. Virol. 85:7402-7410. http://dx.doi.org/10.1128/JVI.02391-10.